I think on the financials alone this could be a real bargain, for instance balance sheet now not much of an issue.
so....why no re-rate or any evidence of insto interest?
Ann: Quarterly Activities and Cashflow Reports, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.76M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80421 | 3.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 666873 | 2 |
View Market Depth
| Last trade - 16.12pm 21/06/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable